Clinical trial
A Relative Bioavailability Study of Metformin HCL 500 mg XR Tablets Under Fasting Conditions
NCT00882882 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Relative Bioavailability Study of Metformin HCL 500 mg XR Tablets Under Fasting Conditions
- Lead sponsor
- Sandoz
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2001
- Completion date
- June 30, 2001
- Enrollment
- 16 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type ii diabetes